News Bioptimus, Cancer Research Horizons partner on AI-powered pr... Bioptimus, a global AI biotech company, has announced a partnership with Cancer Research Horizons, the innovation engine of Cancer Research UK.
News Bioptimus raises $41m for its GenAI model for biology AI startup Bioptimus takes its funding above $76m as it prepares for the launch of a universal foundation model for pathology later this year.
News Bioptimus born with $35m for a foundation model for biology A team of scientists formerly working at Google DeepMind and Owkin have joined forces to create Bioptimus, a start-up that will apply generative artificial intelligence (G
News Roche joins the oral SERD club as FDA clears Wilserdly Roche is the latest drugmaker to bring an oral SERD drug for breast cancer to the US market, after getting FDA approval for its Wilserdly product.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.